In the BioHarmony Drug Report Database

"Preview" Icon

Gabapentin

Gralise, Neurontin (gabapentin) is a small molecule pharmaceutical. Gabapentin was first approved as Gralise on 1993-12-30. It is used to treat bipolar disorder, epilepsy, partial epilepsies, phobic disorders, and postherpetic neuralgia in the USA. It is known to target potassium voltage-gated channel subfamily KQT member 3 and potassium voltage-gated channel subfamily KQT member 5. Gabapentin’s patents are valid until 2024-02-26 (FDA).

 

Trade Name

 

Gralise, Neurontin
 

Common Name

 

gabapentin
 

ChEMBL ID

 

CHEMBL940
 

Indication

 

bipolar disorder, epilepsy, partial epilepsies, phobic disorders, postherpetic neuralgia
 

Drug Class

 

Gabamimetics

Image (chem structure or protein)

Gabapentin structure rendering